心肺運動測試市場規模、佔有率、成長分析（按產品、應用、最終用戶和地區）- 2025 年至 2032 年產業預測

預計 2023 年心肺運動測試市場價值將達到 37 億美元，並從 2024 年的 38.7 億美元成長到 2032 年的 55.9 億美元，預測期內（2025-2032 年）的複合年成長率為 4.7%。

心血管疾病是一個日益嚴重的全球健康危機，需要立即採取行動並改善診斷通訊協定。根據歐洲心臟網路 2021 年的數據，歐盟有超過 6,000 萬人受到影響，每年診斷出近 1,300 萬新病例。這種令人擔憂的流行凸顯了採取積極主動策略的迫切需要，例如實施壓力測試程序以促進早期診斷和介入。心血管疾病的盛行率不斷上升，不僅威脅著個人健康，也給全球醫療保健系統帶來沉重的負擔。因此，迫切需要創新的解決方案和先進的診斷工具來有效解決這一日益嚴重的公共衛生問題並改善受影響人口的預後。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

心肺運動測試市場規模（按產品和複合年成長率）（2025-2032）

• 市場概覽
• 單光子發射電腦斷層掃描（SPECT）
• 心肺運動測試（CPET）系統
• 超音波心臟檢查
• 脈動式血氧監測儀系統
• 壓力血壓計
• 其他

心肺運動測試市場規模（按應用）及複合年成長率（2025-2032）

• 市場概覽
• 氧氣攝入量
• 二氧化碳
• 每分鐘通氣量
• 無氧閾值

心肺運動測試市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 診斷中心
• 門診中心
• 診所
• 醫院
• 其他

心肺運動測試市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

    主要企業簡介

    • COSMED SRL（義大利）
    • 日本光電株式會社（日本）
    • 席勒股份公司（瑞士）
    • Masimo公司（美國）
    • 康德樂（美國）
    • 順泰醫療公司（美國）
    • Geratherm Medical AG（德國）
    • Spacelabs Healthcare（美國）
    • 韋爾奇·阿林（美國）
    • Microlife Medical Home Solutions Inc.（瑞士）
    • Medisoft SA（比利時）
    • CAIRE公司（美國）
    • 艾倫傑斯（印度）
    • Cardioline SpA（義大利）
    • Clarity Medical（印度）
    • Innomed Medical（匈牙利）
    • Valencell（美國）
    • 英科醫療技術股份有限公司 (中國)

結論和建議

Cardiopulmonary Exercise Testing Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.87 billion in 2024 to USD 5.59 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

Cardiovascular diseases are an escalating global health crisis that demands immediate action and improved diagnostic protocols. According to 2021 data from the European Heart Network, over 60 million people in the European Union are affected, with nearly 13 million new diagnoses each year. This alarming prevalence highlights an urgent need for proactive strategies, such as implementing stress testing procedures to facilitate early diagnosis and intervention. The rising incidence of cardiovascular conditions not only threatens individual health but also places significant strain on healthcare systems worldwide. Consequently, there is a pressing requirement for innovative solutions and advanced diagnostic tools to effectively tackle this growing public health issue and improve outcomes for affected populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiopulmonary Exercise Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiopulmonary Exercise Testing Market Segments Analysis

Global Cardiopulmonary Exercise Testing Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Single-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors and Others. Based on Application, the market is segmented into Oxygen Uptake, Carbon Dioxide, Minute Ventilation and Anaerobic Threshold. Based on End User, the market is segmented into Diagnostic Centers, Ambulatory Centers, Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cardiopulmonary Exercise Testing Market

One key market driver for the Global Cardiopulmonary Exercise Testing (CPET) market is the rising prevalence of cardiovascular diseases and respiratory disorders, which necessitates accurate diagnostic tools for effective patient management. As the population ages and lifestyles become more sedentary, the incidence of conditions such as coronary artery disease, chronic obstructive pulmonary disease (COPD), and heart failure continues to climb. This growing patient demographic is driving healthcare providers to adopt CPET as a standard diagnostic procedure, enhancing the demand for advanced exercise testing equipment and services that can evaluate an individual's exercise capacity and cardiovascular response more efficiently.

Restraints in the Cardiopulmonary Exercise Testing Market

The growth of the cardiopulmonary exercise testing market faces significant challenges primarily due to the high costs linked with these diagnostic procedures. The substantial expenses incurred in acquiring, implementing, and maintaining the necessary equipment can act as a major barrier to market expansion. These financial constraints may restrict access to cardiopulmonary exercise testing for healthcare providers and patients alike, potentially hindering its broader acceptance and utilization. Moreover, the economic implications of these tests may present difficulties for healthcare facilities, especially in areas operating under limited budgets, ultimately impacting the overall adoption of this essential diagnostic method.

Market Trends of the Cardiopulmonary Exercise Testing Market

The cardiopulmonary exercise testing market is experiencing noteworthy growth, bolstered by the continuous innovation and diverse offerings from leading industry players. Partnerships, such as the May 2022 collaboration between MGC Diagnostics and UK-based Bedfont Scientific, highlight a strategic focus on integrating advanced technologies, including breath analysis systems like the NObreath fractional exhaled nitric oxide test monitor. Such alliances not only enhance product portfolios but also improve testing capabilities in various settings, from hospitals to remote locations. As these collaborative efforts gain momentum, the market is expected to flourish, driven by advancements that address the increasing demand for comprehensive cardiopulmonary evaluations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cardiopulmonary Exercise Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT)
• Cardiopulmonary Exercise Testing (CPET) Systems
• Echocardiogram
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Others

Global Cardiopulmonary Exercise Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oxygen Uptake
• Carbon Dioxide
• Minute Ventilation
• Anaerobic Threshold

Global Cardiopulmonary Exercise Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Centers
• Ambulatory Centers
• Clinics
• Hospitals
• Others

Global Cardiopulmonary Exercise Testing Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• COSMED SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SunTech Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geratherm Medical AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spacelabs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welch Allyn (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Medical Home Solutions Inc. (Swtzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisoft SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAIRE Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allengers (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardioline SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarity Medical (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innomed Medical (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valencell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INTCO Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations